Device Trial Radar · NCT04600791
BATwire Implant Kit Study
Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
93
Actual
Start
Jan 29, 2021
Primary completion
Aug 28, 2024
Study completion Feb 17, 2025
Sponsor
- Lead sponsor
- CVRx, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 23, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical investigation is to develop valid scientific evidence for the safety and effectiveness of the Barostim System delivered by the BATwire Implant Kit (BATwire Kit) in subjects with heart failure. Subjects may be enrolled if they meet the FDA approved PMA indication for use for the Barostim NEO or Barostim NEO2 device: Subjects who remain symptomatic despite treatment with guideline-directed medical therapy, are NYHA Class III or Class II (who had a recent history of Class III), have a left ventricular ejection fraction ≤ 35%, a NT-proBNP \< 1600 pg/ml and excludes patients indicated for Cardiac Resynchronization Therapy (CRT) according to AHA/ACC/ESC guidelines.
Conditions
- Heart Failure
Interventions
BATwire Implant KitDevice
The BATwire Implant Kit is a delivery system for the placement of the Barostim Carotid Sinus Lead.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Without Serious Adverse Events (SAEs) Related to the Implantation of the Lead Using the BATwire Implant Kit Through 30 Days Post-implant.Time frame: 30 days post-implant
- Change in Six Minute Hall Walk (6MHW) Distance WalkedTime frame: From baseline to 6 months of follow-up, post-implant
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Chan Heart Rhythm Institute
Mesa, Arizona
HonorHealth
Scottsdale, Arizona
AdventHealth
Orlando, Florida
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.